According to Cynata Therapeutics latest financial reports the cash on hand of CYP is $10.94M, an decrease of -32.06% to 2022. At the end of 2022 company had $16.10M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $10.94M | -32.06% |
2022 | $16.10M | -10.92% |
2021 | $18.07M | 95.73% |
2020 | $9.23M | 95.63% |
2019 | $4.72M | - |